| Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy L Motedayen Aval, JE Pease, R Sharma, DJ Pinato Journal of clinical medicine 9 (10), 3323, 2020 | 175 | 2020 |
| Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study S Hajiev, E Allara, L Motedayеn Aval, T Arizumi, D Bettinger, M Pirisi, ... British Journal of Cancer 124 (2), 407-413, 2021 | 22 | 2021 |
| Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: An international cohort study. J Howell, A Samani, B Mannan, S Hajiev, LM Aval, R Abdelmalak, ... Journal of Clinical Oncology 39 (3_suppl), 289-289, 2021 | 8 | 2021 |
| Beyond first-line immune checkpoint inhibitor therapy in patients with hepatocellular carcinoma R Sharma, L Motedayen Aval Frontiers in Immunology 12, 652007, 2021 | 6 | 2021 |
| Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case series L Motedayen Aval, M Boullier, H Lyall, GP Collins, R Ayto, DF Kelly, ... EJHaem 2 (1), 131-135, 2021 | 6 | 2021 |
| Motedayen Aval L R Sharma Beyond first-line immune checkpoint inhibitor therapy in patients with …, 2021 | 6 | 2021 |
| Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study J Howell, A Samani, B Mannan, S Hajiev, L Motedayen Aval, ... Therapeutic advances in gastroenterology 15, 17562848221100106, 2022 | 5 | 2022 |
| Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case series LM Aval, M Boullier, H Lyall, GP Collins, R Ayto, DF Kelly, RS Tedder, ... EJHaem 2 (1), 131, 2021 | 4 | 2021 |
| Motedayen Aval L, Abdelmalak R, Tam VC, Bettinger D, Thimme R, Taddei TH, Kaplan DE, Seidensticker M, Sharma R J Howell, A Samani, B Mannan, S Hajiev Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated …, 2022 | 3 | 2022 |
| Methodological and ethical challenges in the use of focused ultrasound for blood–brain barrier disruption in neuro-oncology SG Thavarajasingam, JL Kilgallon, DSC Ramsay, LM Aval, IA Tewarie, ... Acta Neurochirurgica 165 (12), 4259-4277, 2023 | 1 | 2023 |
| Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study S Hajiev, E Allara, LM Aval, T Arizumi, D Bettinger, M Pirisi, L Rimassa, ... British Journal of Cancer 124 (9), 1611, 2021 | 1 | 2021 |
| An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib. R Sharma, S Hajiev, LM Aval, D Bettinger, T Arizumi, M Pirisi, L Rimassa, ... Journal of Clinical Oncology 38 (15_suppl), 12049-12049, 2020 | | 2020 |
